Usability of Nasal Glucagon Device: Partially Randomized Caregiver and Third-Party User Experience Trial with Simulated Administration at a Japanese Site

INTRODUCTION: Glucagon is the only approved medicine for severe hypoglycemia available for caregivers of people with diabetes. Nasal glucagon (NG) was recently approved in the USA as a needle-free, ready-to-use alternative to injectable glucagon. This simulated user experience study in Japan compare...

Descripción completa

Detalles Bibliográficos
Autores principales: Aranishi, Toshihiko, Nagai, Yukiko, Takita, Yasushi, Zhang, Shuyu, Nishimura, Rimei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6965568/
https://www.ncbi.nlm.nih.gov/pubmed/31686354
http://dx.doi.org/10.1007/s13300-019-00711-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6965568/
https://www.ncbi.nlm.nih.gov/pubmed/31686354
http://dx.doi.org/10.1007/s13300-019-00711-1

Ejemplares similares